Pro Medicus Limited (ASX:PME – Get Free Report) insider Anthony Hall purchased 8,146 shares of Pro Medicus stock in a transaction on Thursday, February 26th. The stock was acquired at an average cost of A$122.00 per share, for a total transaction of A$993,812.00.
Anthony Hall also recently made the following trade(s):
- On Wednesday, February 25th, Anthony Hall purchased 9,000 shares of Pro Medicus stock. The shares were acquired at an average cost of A$114.41 per share, for a total transaction of A$1,029,690.00.
- On Tuesday, February 24th, Anthony Hall bought 8,500 shares of Pro Medicus stock. The stock was acquired at an average cost of A$110.13 per share, for a total transaction of A$936,105.00.
- On Tuesday, December 23rd, Anthony Hall purchased 2,270 shares of Pro Medicus stock. The shares were acquired at an average cost of A$220.31 per share, with a total value of A$500,103.70.
- On Monday, December 22nd, Anthony Hall acquired 2,250 shares of Pro Medicus stock. The shares were bought at an average price of A$221.90 per share, for a total transaction of A$499,275.00.
Pro Medicus Stock Performance
The firm has a market cap of $29.16 billion, a P/E ratio of 351.99, a PEG ratio of 3.87 and a beta of 0.56. The company has a debt-to-equity ratio of 1.10, a current ratio of 5.98 and a quick ratio of 4.39.
Pro Medicus Announces Dividend
About Pro Medicus
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products.
Further Reading
- Five stocks we like better than Pro Medicus
- Gold Ran First – but This Cycle May Belong to Silver
- REVEALED: Something Big Happening Behind White House Doors
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- Gilder: Don’t Buy AI Stocks, Do This Instead
- Read this or regret it forever
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
